Title
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: An individual patient data meta-analysis
Date Issued
15 November 2014
Access level
open access
Resource Type
journal article
Author(s)
Bastos M.L.
Hussain H.
Weyer K.
Garcia-Garcia L.
Leimane V.
Leung C.C.
Narita M.
Penã J.M.
Ponce-De-leon A.
Seung K.J.
Shean K.
Sifuentes-Osornio J.
Van Der Walt M.
Van Der Werf T.S.
Yew W.W.
Menzies D.
Ahuja S.D.
Ashkin D.
Avendano M.
Banerjee R.
Bauer M.
Becerra M.C.
Benedetti A.
Burgos M.
Centis R.
Chan E.D.
Chiang C.Y.
Cox H.
D'Ambrosio L.
Deriemer K.
Dung N.H.
Enarson D.
Falzon D.
Flanagan K.
Flood J.
Garcia-Garcia M.L.
Gandhi N.
Granich R.M.
Hollm-Delgado M.G.
Holtz T.H.
Iseman M.D.
Jarlsberg L.G.
Keshavjee S.
Kim H.R.
Koh W.J.
Lancaster J.
Lange C.
De Lange W.C.M.
Li J.
Migliori G.B.
Mishustin S.P.
Mitnick C.D.
O'Riordan P.
Pai M.
Palmero D.
Park S.K.
Pasvol G.
Pena J.
Pérez-Guzmán C.
Quelapio M.I.D.
Riekstina V.
Robert J.
Royce S.
Schaaf H.S.
Shah L.
Shim T.S.
Shin S.S.
Shiraishi Y.
Sotgiu G.
Strand M.J.
Tabarsi P.
Tupasi T.E.
Van Altena R.
Van Der Werf T.S.
Vargas M.H.
Viiklepp P.
Westenhouse J.
Yim J.J.
Federal University of Rio de Janeiro
Publisher(s)
Oxford University Press
Abstract
Background: Individualized treatment for multidrug-resistant (MDR) tuberculosis and extensively drugresistant (XDR) tuberculosis depends upon reliable and valid drug susceptibility testing (DST) for pyrazinamide, ethambutol, and second-line tuberculosis drugs. However, the reliability of these tests is uncertain, due to unresolved methodological issues. We estimated the association of DST results for pyrazinamide, ethambutol, and second-line drugs with treatment outcomes in patients with MDR tuberculosis and XDR tuberculosis.
Start page
1364
End page
1374
Volume
59
Issue
10
Language
English
OCDE Knowledge area
Salud pública, Salud ambiental
Enfermedades infecciosas
Subjects
Scopus EID
2-s2.0-84918817893
PubMed ID
Source
Clinical Infectious Diseases
ISSN of the container
10584838
Sponsor(s)
Centers for Disease Control and Prevention
Howard Hughes Medical Institute
South African Medical Research Council
Fogarty International Center D43TW007887
Sources of information:
Directorio de Producción Científica
Scopus